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POS-1 and GLD-1 repress glp-1 translation 
through a conserved binding-site cluster
Brian M. Farley and Sean P. Ryder
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 
Worcester, MA 01605
ABSTRACT RNA-binding proteins (RBPs) coordinate cell fate specification and differentiation 
in a variety of systems. RNA regulation is critical during oocyte development and early em-
bryogenesis, in which RBPs control expression from maternal mRNAs encoding key cell fate 
determinants. The Caenorhabditis elegans Notch homologue glp-1 coordinates germline 
progenitor cell proliferation and anterior fate specification in embryos. A network of se-
quence-specific RBPs is required to pattern GLP-1 translation. Here, we map the cis-regulato-
ry elements that guide glp-1 regulation by the CCCH-type tandem zinc finger protein POS-1 
and the STAR-domain protein GLD-1. Our results demonstrate that both proteins recognize 
the glp-1 3′ untranslated region (UTR) through adjacent, overlapping binding sites and that 
POS-1 binding excludes GLD-1 binding. Both factors are required to repress glp-1 translation 
in the embryo, suggesting that they function in parallel regulatory pathways. It is intriguing 
that two equivalent POS-1–binding sites are present in the glp-1 3′ UTR, but only one, which 
overlaps with a translational derepression element, is functional in vivo. We propose that 
POS-1 regulates glp-1 mRNA translation by blocking access of other RBPs to a key regula-
tory sequence.
INTRODUCTION
The physiology of a cell is governed by the identity and extent of 
genes that it expresses. Gene expression is regulated at the tran-
scriptional, posttranscriptional, and posttranslational levels. Each 
aspect is important and necessary to ensure appropriate expression 
for a given cell type. The relative importance of each varies, de-
pending on cell lineage and activity. For example, control of gene 
expression after transcription is of primary importance during early 
embryogenesis, when transcription is repressed due to continuous 
DNA replication (Newport and Kirschner, 1982; Batchelder et al., 
1999; Tadros and Lipshitz, 2009), and in cells in which physiology is 
partially decoupled from the nucleus due to size or morphology, 
such as neurons (Swanger and Bassell, 2011). In such situations, 
RNA-binding proteins and small RNA–protein complexes function 
as critical regulatory factors that control mRNA stability, subcellular 
localization, and translation efficiency to guide cell function.
To coordinate gene expression, RNA-regulatory factors must se-
lect specific target transcripts from the set of all transcripts present 
in the cell. A variety of high-throughput methods, including cross-
linked immunoprecipitation with deep sequencing (Licatalosi et al., 
2008; Hafner et al., 2010) and RNA immunoprecipitation coupled 
with array- or deep sequencing-based detection (Kershner and 
Kimble, 2010; Wright et al., 2011), reveal that some RNA-regulatory 
factors interact with hundreds or thousands of mRNA targets. 
Although the number is large, it is in many cases less than one might 
expect based solely upon predictions from corresponding in vitro 
binding studies (Ryder et al., 2004; Bernstein et al., 2005; Wright 
et al., 2011). In contrast, functional assays routinely show that only a 
few RNA targets contribute to the phenotype observed upon loss of 
the RNA-regulatory factor (Lee and Schedl, 2001; Hansen et al., 
2004; Kalchhauser et al., 2011), suggesting that most binding events 
are either unproductive or not important to cellular function. The 
apparent disparity between in vitro binding, in vivo binding, and 
functional data reveals that the basis for specific target selection is 
not well understood.
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four-cell embryo (Mickey et al., 1996). GLP-1 protein is restricted 
to these locations in the germline and embryo (Figure 1A); how-
ever, glp-1 mRNA is present throughout the entire gonad and all 
cells of the early embryo (Evans et al., 1994). glp-1 translational 
repression requires at least five different RNA-binding proteins, 
each repressing translation at different times during develop-
ment: the STAR-domain protein GLD-1 acts in germ cells entering 
meiosis (Francis et al., 1995; Kadyk and Kimble, 1998), the PUF 
family members PUF-5/6 and PUF-7 act during oogenesis (Lublin 
and Evans, 2007), the KH-domain protein MEX-3 acts after fertil-
ization (Pagano et al., 2009), and both GLD-1 and the CCCH-type 
tandem zinc finger protein POS-1 are required in the posterior of 
early embryos (Ogura et al., 2003; Marin and Evans, 2003; Figure 
1B). In addition, the RRM-domain protein SPN-4 is required for 
translational activation of glp-1 in the early embryo (Ogura et al., 
2003).
Mutational analysis of the glp-1 3′ UTR has identified a 34-nucle-
otide region that is sufficient to spatially pattern a reporter (Marin 
and Evans, 2003). This region can be further subdivided into two 
regulatory elements: the glp-1 repression element (GRE) and the 
glp-1 derepression element (GDE; Marin and Evans, 2003). Muta-
tions within the GRE result in an expanded reporter expression pat-
tern in the gonad and excess reporter expression in the posterior of 
early embryos. On the other hand, mutations of the GDE result in 
either decreased or no reporter expression in either the gonad or 
embryos (Marin and Evans, 2003). GLD-1 directly associates with 
the GRE in a sequence-specific manner, suggesting that GLD-1 
translationally represses glp-1 through the GRE (Marin and Evans, 
2003). Given the proximity of the GDE and the GRE, it has been 
hypothesized that another RNA-binding protein inhibits GLD-1 as-
sociation with the GRE by binding to the GDE (Marin and Evans, 
2003; Figure 2).
We previously mapped a binding site for POS-1 (POS-1 recogni-
tion element [PRE]; Farley et al., 2008) within the GDE that partially 
overlaps with the GLD-1–binding motif (GBM; Wright et al., 2011) in 
the GRE, suggesting that POS-1 could function as the glp-1 activa-
tor through competition with GLD-1 (Figure 2). In contrast, muta-
tional studies suggest that POS-1 acts to repress glp-1 translation, 
possibly in complex with GLD-1, and a different factor functions as 
Posttranscriptional regulation of mRNA is primarily mediated 
through cis-regulatory elements present in the untranslated re-
gions (UTRs) of the transcript. These regions are not subject to the 
evolutionary constraint of the genetic code and thus can primarily 
serve a regulatory role. A survey of germline-expressed genes in 
the nematode Caenorhabditis elegans demonstrates that 3′ UTRs 
are sufficient to drive patterned gene expression in the germline 
(Merritt et al., 2008). Transgenic worms carrying a fluorescent re-
porter that included only the 3′ UTR of the gene being investi-
gated recapitulated the expression pattern of the endogenous 
protein in 24 of 30 cases (Merritt et al., 2008). In addition, most 
transcripts do not contain a unique 5′ UTR, as 5′-end formation in 
nematodes is mediated primarily by trans-splicing of one of two 
leader sequences (Allen et al., 2011). Thus the C. elegans germline 
provides an ideal model system in which the selection of biologi-
cally relevant mRNA targets by sequence-specific RNA-binding 
proteins can be examined.
Studies of translationally regulated transcripts in C. elegans 
development reveal that multiple RNA-binding proteins contrib-
ute to the regulation of a single mRNA (Jadhav et al., 2008; 
Pagano et al., 2009). One example of this is the transcript encod-
ing the C. elegans Notch receptor homologue glp-1. GLP-1 is a 
critical regulator of at least two distinct developmental pathways. 
It is the central regulator of the mitosis-to-meiosis switch in the 
distal arm of the gonad (Austin and Kimble, 1987), and it is re-
quired for specifying endodermal cell fates in the anterior of the 
FIGURE 1: POS-1 and GLD-1 expression is anticorrelated with GLP-1 
expression. (A) Schematic of GLD-1 and GLP-1 expression in the 
germline. GLP-1 expression (green) is restricted to germ cells in 
mitosis, whereas GLD-1 (red) is expressed in the meiotic syncytium. 
GLD-1 is expressed diffusely in the cytoplasm, as well as in P-body–
like granules. (B) Schematic of GLP-1, POS-1, and GLD-1 expression in 
embryos. Embryos are oriented with the anterior to the left. glp-1 
mRNA (light green) is expressed in all cells of the early embryo, 
whereas GLP-1 protein (dark green) is not expressed until the four-cell 
stage and is restricted to the surface of the two anterior blastomeres 
(ABa and ABp). POS-1 (blue) is expressed in the posterior cytoplasm 
of early embryos from the one-cell stage. POS-1 localizes to 
perinuclear P-granules in the germline P-lineage of embryos. GLD-1 
(red) expression begins at the four-cell stage, and it is present in the 
two posterior blastomeres. GLD-1 is found in the cytoplasm, in 
perinuclear P-granules in the P-lineage, and in granules distributed 
throughout both cells of the four-cell stage.
FIGURE 2: POS-1–and GLD-1–binding sites lie within regulatory 
elements of the glp-1 3′ UTR. The GRE is adjacent to the GDE (top), 
and both overlap with predicted POS-1 recognition elements (PRE, 
blue) and a GLD-1 binding motif (GBM, red). Mutations across this 
region in the context of a reporter (left, above the line) result in 
various expression patterns, listed to the right. The mutations used in 
this study are listed below the line.
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RESULTS
Identification of a second PRE in the 
glp-1 3′ UTR
In a previous report (Farley et al., 2008), we 
used quantitative in vitro binding studies to 
define the POS-1 consensus recognition el-
ement and used the pattern-matching tool 
PatScan (Dsouza et al., 1997) to identify pu-
tative PREs in annotated C. elegans 3′ UTRs 
based upon this sequence. PatScan identi-
fies binding motifs using a text-string match-
ing algorithm (Dsouza et al., 1997). This 
analysis revealed a single PRE in the glp-1 3′ 
UTR; however, we noticed that the search 
pattern does not accurately reflect the ther-
modynamic measurements in a special case 
in which a single-nucleotide deletion com-
pensates for an otherwise deleterious muta-
tion. Specifically, mutation of the adenosine 
at position 6 of the PRE to a cytosine re-
duces binding by 0.6 kcal/mol (Farley et al., 
2008), whereas reducing the number of in-
tervening nucleotides between positions 6 
and 10 improves binding by the same 
amount (Farley et al., 2008). When we apply 
the revised pattern to the glp-1 3′ UTR, we 
observe a second putative PRE that lies im-
mediately upstream from the GBM, such 
that the last nucleotide of the PRE corre-
sponds to the first nucleotide of the GBM. 
As such, the GBM is flanked by two PREs, 
each overlapping the GBM by one nucle-
otide (Figure 2).
POS-1 and GLD-1 recognize the glp-1 
3′ UTR in a sequence-specific manner
To determine whether POS-1 and GLD-1 
recognize their predicted binding sites in the glp-1 3′ UTR, we ex-
pressed and purified N-terminal maltose-binding protein fusions of 
the RNA-binding domains of POS-1 (amino acids 1–206) and GLD-1 
(amino acids 135–336) for use in quantitative fluorescence electro-
phoretic mobility shift assays (F-EMSAs). Truncations of both pro-
teins were used because of the difficulty of purifying sufficient quan-
tities of full-length protein to perform in vitro binding experiments. 
The in vitro specificity of GLD-1(135-336) correlates well with en-
riched sequence motifs present in mRNAs coimmunoprecipitated 
with GLD-1 from whole-worm extract (Wright et al., 2011), whereas 
POS-1(1-206) lacks 58 amino acids with no homology to known do-
mains. These proteins were used in F-EMSA along with a 34-nucle-
otide RNA fragment of the glp-1 3′ UTR that contains both PREs, the 
GBM, and flanking sequences (Table 1 and Figure 3). The fraction of 
bound RNA was plotted as a function of total protein concentration 
and fit to the Hill equation to determine the apparent dissociation 
constant (Kd,app) and Hill coefficient (n). By this method, both POS-
1(1-206) and GLD-1(135-336) bind to this fragment with high affinity 
(POS-1(1-206), Kd,app = 19 ± 2 nM and n = 1.3 ± 0.2; GLD-1(135-
336), Kd,app = 70 ± 10 nM and n = 1.0 ± 0.2; Table 1 and Figure 3).
To determine whether binding of each protein is dependent on 
its respective binding sites, we designed RNA oligonucleotides con-
taining mutations in either the PREs or the GBM (Table 1 and Figure 
3). Based on previous studies, the mutations were predicted to re-
duce the affinity of each protein for this sequence by >10-fold. 
the activator (Marin and Evans, 2003). Of importance, none of the 
mutations that have been made across the GRE and GDE is pre-
dicted to exclusively perturb POS-1 binding (Figure 2), so it remains 
unclear what role POS-1 plays in regulating glp-1 or whether regula-
tion is direct.
POS-1 and GLD-1 exhibit different expression patterns in the 
early embryo. POS-1 is first observed in the posterior of the one-
cell embryo and is expressed in the posterior blastomeres of the 
embryo through the four-cell stage. POS-1 is present throughout 
the cytoplasm of the cells in which it is expressed, as well as in 
perinuclear granules called P-granules in the germline precursor 
blastomeres (Tabara et al., 1999). In contrast, GLD-1 is first ex-
pressed in the posterior blastomeres of the four-cell stage and it 
localizes to cytoplasmic granules in the cells in which it is expressed 
(Jones et al., 1996). In addition to the cytoplasmic granules, GLD-1 
also localizes to P-granules (Jones et al., 1996; Figure 1B). Thus 
POS-1 and GLD-1 may associate with glp-1 mRNA in different sub-
cellular locations.
To determine the individual roles of both POS-1 and GLD-1 in 
regulating glp-1, we identify mutations that perturb binding of 
POS-1 or GLD-1 individually and use them to generate fluorescent 
reporters to measure their relative contribution to the regulation of 
glp-1 expression in vivo. The results reveal that POS-1 is indeed a 
repressor of glp-1 translation, but it acts independently of GLD-1, 
and its activity is highly context dependent.
FIGURE 3: POS-1 and GLD-1 recognize the glp-1 3′ UTR in a sequence-specific manner. 
Fluorescence electrophoretic mobility shift assays with recombinant POS-1(1-206) (left) and 
GLD-1(135-329) (right) and fluorescently labeled fragments of the glp-1 3′ UTR. Top, gel shift 
images. Bottom, quantifications and fits. POS-1(1-206) binds to the wild-type glp-1 fragment 
with Kd,app = 19 ± 2 nM, mutation of either PRE individually reduces binding ∼2.5-fold (∆5′ PRE, 
Kd,app = 54 ± 4 nM; ∆3′ PRE, Kd,app = 52 ± 1 nM), and mutation of both reduces binding ∼15-fold 
(∆5′ 3′ PRE, Kd,app = 310 ± 20 nM). GLD-1(135-329) binds to the wild-type glp-1 fragment with 
Kd,app = 70 ± 10 nM, and mutation of the GBM almost completely abrogates binding (∆GBM, 
Kd,app > 2000 nM). Reported Kd,app values are the average ± SD of three independent replicates.
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and B). At high POS-1(1-206) concentration (>300 nM), nonspecific 
POS-1(1-206) binding obscured visibility of residual GLD-1(135-336) 
complex (Figure 4, A and B). In contrast, when GLD-1(135-336) 
is titrated into samples containing 100 nM POS-1(1-206), no 
GLD-1(135-336) complex is observed, even when GLD-1(135-336) is 
present at a concentration that is 10-fold greater than POS-1(1-206) 
(Figure 4, A and B). No evidence of a slower-mobility species is ap-
parent, suggesting that efficient ternary complex formation does not 
happen. Because the RNA contains two POS-1–binding sites that 
overlap with the single GLD-1–binding site and because the appar-
ent affinity of POS-1(1-206) is 3.5-fold tighter than the apparent af-
finity of GLD-1(135-336), this is the expected result if the proteins 
compete for binding to the RNA fragment. Similar results were 
obtained when the experiment was repeated with a shorter variant 
of POS-1 containing only the RNA-binding domain (POS-1-RBD, 
amino acids 80–180; Figure 4, C and D). This construct binds to the 
glp-1 fragment with similar affinity to that of the longer construct 
(Kd,app,POS-1-RBD = 30 ± 17 nM; Supplemental Figure S1) but provides 
greater resolution of the POS-1(80-180)– and GLD-1(135-336)–
bound complexes. POS-1(80-180) efficiently competed with 
GLD-1(135-336) for binding to the glp-1 fragment, whereas 
GLD-1(135-336) complex formation was strongly inhibited by 
POS-1(80-180). Taken together, the data show that POS-1 and GLD-1 
do not simultaneously bind the glp-1 3′ UTR fragment and suggest 
that POS-1 could inhibit GLD-1 binding to the glp-1 3′ UTR in vivo.
Mutations in the glp-1 3′ UTR are specific for either 
POS-1 or GLD-1
To individually determine the regulatory contribution of direct bind-
ing of POS-1 or GLD-1 to the glp-1 3′ UTR, we designed mutants 
that would exclusively affect either POS-1 or GLD-1 binding. To de-
termine whether the mutations designed to inhibit binding of either 
POS-1 or GLD-1 to the glp-1 3′ UTR do not interfere with the bind-
ing of the other protein, we used quantitative EMSA to measure the 
affinity of POS-1(1-206) for the ∆GBM version of the glp-1 fragment 
and the affinity of GLD-1(135-336) for the ∆5′, 3′ PRE sequence. 
Mutation of the GBM does not change the apparent affinity of 
POS-1(1-206) (Kd,app WT = 19 ± 2 nM and Kd,app ∆GBM = 21 ± 1 nM), 
indicating that single-nucleotide GBM mutation does not affect 
POS-1(1-206) binding. Mutation of both PREs results in a threefold 
increase in GLD-1(135-336) affinity (Kd,app WT = 70 ± 10 nM and 
Kd,app ∆PRES = 20 ± 4 nM; Supplemental Figure S2), which is statisti-
cally significant (p = 0.008), suggesting that mutations in the POS-1–
binding sites weakly increase the affinity of GLD-1(135-336) for the 
glp-1 3′ UTR.
Both POS-1 and GLD-1 binding are required for repression 
of glp-1 translation in embryos
To determine whether direct binding of POS-1 to the glp-1 3′ UTR 
antagonizes GLD-1 and thus derepresses glp-1 translation in early 
Mutation of both PREs results in an 15-fold reduction in affinity for 
POS-1(1-206) (Kd,app = 310 ± 20 nM), whereas mutation of the GBM 
results in almost complete abrogation of binding of GLD-1(135-336) 
(Kd,app > 2000 nM). Thus both POS-1(1-206) and GLD-1(135-336) 
recognize the glp-1 3′ UTR in a binding site–dependent manner 
(Figure 3B).
The PREs are equivalent and independent
Given that only one of the PREs in the glp-1 fragment perfectly 
matches the previously published consensus, we wanted to deter-
mine whether POS-1(1-206) recognized each binding site. To test 
the contribution of each site individually, we designed oligonucle-
otides bearing mutations in only one of the PREs and performed 
EMSA experiments with POS-1(1-206). Mutation of either PRE re-
sulted in a 2.5-fold reduction in binding compared with the wild-
type sequence (Kd,app WT = 19 ± 2 nM, Kd,app ∆5′ PRE = 54 ± 4 nM, and 
Kd,app ∆3′ PRE = 52 ± 1 nM), demonstrating that each site is recog-
nized by POS-1(1-206) with equivalent affinity (Figure 3B).
To determine whether the two equivalent PREs in the glp-1 3′ 
UTR are independent, we analyzed the relationship between the 
macroscopic and microscopic dissociation constants. An RNA with 
two equivalent, independent binding sites for a protein for which 
only one site is occupied at any given time should have a macro-
scopic dissociation constant that is twofold tighter than the micro-
scopic dissociation constants observed for either in isolation due to 
statistical effects. We observe a 2.5-fold decrease in affinity between 
the glp-1 fragments with one intact PRE versus the wild-type se-
quence, suggesting that the two PREs are both equivalent and inde-
pendent. This hypothesis is further supported by the unchanged Hill 
coefficients of the individual-site mutants versus the wild-type se-
quence (nWT = 1.3 ± 0.2, n∆5′ PRE = 1.7 ± 0.5, and n∆3′ PRE = 1.5 ± 0.3), 
as cooperative binding to the wild-type sequence is expected to 
increase the Hill coefficient.
POS-1(1-206) antagonizes GLD-1(135-336) binding 
to the glp-1 3′ UTR
Given that each of two independent POS-1–binding sites overlaps 
with the GBM, we hypothesized that POS-1(1-206) binding may in-
hibit GLD-1(135-336) binding to the glp-1 3′ UTR. To test this hypoth-
esis, we performed in vitro competition gel shift experiments with 
POS-1(1-206) and GLD-1(135-336). In these experiments, a range of 
concentrations of the competitor protein was titrated into a fixed, 
trace concentration of fluorescently labeled RNA and a fixed sub-
saturating concentration of the other protein. The differently bound 
species of RNA were resolved from one another by electrophoresis 
on a native polyacrylamide gel.
When POS-1(1-206) was titrated into samples containing 400 nM 
GLD-1(135-336) and labeled RNA, we observed a decrease in the 
amount of GLD-1(135-336)–RNA complex and corresponding for-
mation of faster-mobility POS-1(1-206)–RNA complex (Figure 4, A 
Identifier Sequence POS-1 Kd,app (nM) GLD-1 Kd,app (nM)
glp-1 WT UUUUUCUUAUUCUAGACUAAUAUUGUAAGCU 19 ± 2 70 ± 10
∆GBM UUUUUCUUAUUCUAGACCAAUAUUGUAAGCU 21 ± 1 2000
∆5′ PRE UUUUUCUCCCUCUAGACUAAUAUUGUAAGCU 55 ± 4 33 ± 7
∆3′ PRE UUUUUCUUAUUCUAGACUAACCCUGUAAGCU 53 ± 1 25 ± 3
∆5′ 3′ PRE UUUUUCUCCCUCUAGACUAACCCUGUAAGCU 310 ± 20 20 ± 3
Reported Kd,app values are the mean ± one SD of three independent replicates.
TABLE 1: Dissociation constants of POS-1 and GLD-1 for variants of the glp-1 fragment.
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relative to oogenesis (Frand et al., 2005), the open reading frame 
also contains the mouse ornithine decarboxylase PEST domain, 
which destabilizes the protein (Frand et al., 2005). To enable direct 
comparison of the reporter expression patterns resulting from differ-
ent transgenic constructs, the transgenes were integrated site spe-
cifically into chromosome II using Mos1-mediated single-copy inser-
tion of transgenes (MosSCI; Frøkjaer-Jensen et al., 2008; Figure 5A).
To determine the effects on reporter translation in embryos 
of disrupting POS-1 or GLD-1 binding to the glp-1 3′ UTR, we 
embryos, we generated green fluorescent protein (GFP) reporters 
carrying the wild-type glp-1 3′ UTR or the mutant variations charac-
terized in vitro (Table 2). To ensure that we were observing only the 
posttranscriptional regulation of glp-1, our reporters used the mex-5 
promoter, a germline promoter with a similar expression pattern to 
the glp-1 promoter. The open reading frame of each reporter en-
codes a protein fusion of GFP and C. elegans histone 2B (H2B), which 
concentrates the fluorescence signal in the nucleus and facilitates 
cell identification. Because the half-life of both GFP and H2B is long 
FIGURE 4: POS-1 antagonizes GLD-1 to the glp-1 fragment. (A) Gels of competition experiments with POS-1(1-206) 
and GLD-1(135-329). Top, POS-1(1-206) is titrated into a fixed concentration of GLD-1(135-329). Bottom, 
GLD-1(135-329) is titrated into a fixed concentration of POS-1(1-206). The mobilities of POS-1–bound RNA, 
GLD-1–bound RNA, and free RNA are labeled to the left of the gels. (B) Quantifications of POS-1(1-206) competition 
experiments. Left, POS-1(1-206) is titrated into a fixed concentration of GLD-1(135-329). Right, GLD-1(135-329) is 
titrated into a fixed concentration of POS-1(1-206). In both plots, fraction of total RNA bound by each protein is plotted 
against the concentration of the titrated protein. Filled circles, POS-1–bound RNA. Open circles, GLD-1–bound RNA. 
(C, D). Competition experiments with POS-1(80-180) and GLD-1(135-329). The gels in C are labeled as in A, and the 
plots in D are labeled as in B.
glp-1 3′ UTR 
variant
Strain  
identifier Genotype
WT WRM5 sprSi5[Pmex-5::MODC PEST:GFP:H2B::glp-1 3′UTR cb-unc-119(+)] II, unc-119(ed3) III
∆GBM WRM6 sprSi6[Pmex-5::MODC PEST:GFP:H2B::glp-1 3′UTR(∆GBM) cb-unc-119(+)] II, unc-119(ed3) III
∆5′ PRE WRM7 sprSi7[Pmex-5::MODC PEST:GFP:H2B::glp-1 3′UTR(∆5′ PRE) cb-unc-119(+)] II, unc-119(ed3) III
∆3′ PRE WRM8 sprSi8[Pmex-5::MODC PEST:GFP:H2B::glp-1 3′UTR(∆3′ PRE) cb-unc-119(+)] II, unc-119(ed3) III
∆5′ 3′ PRE WRM9 sprSi9[Pmex-5::MODC PEST:GFP:H2B::glp-1 3′UTR(∆5′ 3′ PRE) cb-unc-119(+)] II, unc-119(ed3) III
TABLE 2: Transgenic worm strains used in this study.
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is sufficient for appropriate patterning, and the reporter mimics the 
expression pattern of endogenous GLP-1, as previously reported 
(Evans et al., 1994). On treatment with pos-1(RNAi), 100% of em-
bryos express GFP in all cells of the four-cell-stage embryo (n = 8; 
Figure 5, B and C), suggesting that POS-1 protein plays an inhibitory 
role in the translational regulation of glp-1. POS-1 may have indirect 
effects on the translation of glp-1, so to investigate the requirement 
for POS-1 binding, we examined a reporter with both PREs mutated. 
Mutation of both PREs results in a similar expression pattern as that 
for embryos carrying the wild-type reporter treated with pos-1(RNAi) 
(94% express in posterior, n = 16; Figure 5, B and C), suggesting that 
the PREs are required for translational repression rather than dere-
pression of glp-1 and that POS-1 directly regulates glp-1. Because 
the two PREs are equivalent and independent, we hypothesized 
that the two binding sites are redundant. To test this hypothesis and 
determine the individual contribution of each PRE, we generated 
transgenic strains bearing mutations in either the 5′ or 3′ PRE. 
Mutating the 5′ PRE results in embryos exhibiting wild-type GFP 
expression (anterior, 43%; no expression, 57%; n = 21; Figure 5, B 
and C), whereas mutating the 3′ PRE results in ubiquitously ex-
pressed GFP at the four-cell stage (82% express in posterior, n = 27; 
Figure 5, B and C). This suggests that despite the equivalent affini-
ties of the PREs in vitro, only the 3′ PRE is required for POS-1–medi-
ated translational repression of glp-1.
Given that POS-1 binding is essential for translational repression 
of glp-1 and that GLD-1 does not bind to the glp-1 3′ UTR in the 
presence of POS-1 in vitro, we wanted to revisit the role of the GBM 
in embryos compared with the germline, where GLD-1 is present but 
POS-1 is not. To test this hypothesis, we generated a transgenic line 
carrying a mutation in the GBM and observed four-cell-stage em-
bryos. Embryos carrying this transgene express GFP in all cells of the 
early embryo (87% express in posterior, n = 30; Figure 5, B and C), 
suggesting that the GBM is also required for translational repression 
of glp-1 in the embryo. This matches the previously published results 
for both the endogenous GLP-1 expression pattern in gld-1(RNAi) 
embryos (Marin and Evans, 2003) and for reporters carrying muta-
tions in the GRE (Marin and Evans, 2003), confirming that GLD-1 acts 
through the GRE to repress glp-1 translation in the embryo.
The 3′ PRE mutations disrupt the GDE in the germline
The 3′ PRE mutation lies entirely within the GDE, which is required 
for translational activation of glp-1 but results in delocalized expres-
sion in the embryo. We wanted to determine the effect of the PRE 
mutations on germline expression of the glp-1 reporter. The gonads 
of live worms were observed by confocal fluorescence microscopy 
(Figure 6A). To compare the GFP expression level between strains, 
we imaged confocal sections through the syncytial region of the 
gonad of multiple worms for each strain. For each image, the mean 
pixel intensity across one row of nuclei within the distal arm of the 
gonad was determined using the image quantification software Im-
ageJ (Schneider et al., 2012). To normalize for differences in the 
lengths of gonad arms, the measured pixel intensities for each im-
age were divided into 30 segments, and intensities within segments 
were averaged together. Single-worm segmented intensity mea-
surements for one transgenic strain were averaged to give a com-
posite average intensity for each strain (Figure 6B).
Worms carrying the wild-type (WT) reporter have maximum GFP 
expression in the distal end of the germline, with diminishing ex-
pression in the meiotic region (Figure 6B; glp-1 WT, n = 17). This 
closely matches the expression of endogenous GLP-1 in the ger-
mline (Crittenden et al., 1994). Mutation of the 5′ PRE has no effect 
on expression of GFP, consistent with the effects observed in 
dissected adult worms and observed live four-cell-stage embryos. 
Endogenous GLP-1 is expressed only in the two anterior blastom-
eres at the four-cell stage (Evans et al., 1994). If direct binding of 
GLD-1 is required for translational repression, mutating the GBM 
should result in reporter expression in the posterior as well as the 
anterior of the four-cell-stage embryo. If POS-1 antagonizes GLD-1 
binding and thus leads to derepression, neither anterior nor poste-
rior expression of the reporter should be observed when the PREs 
are mutated. Thirty-three percent of embryos carrying the WT re-
porter express GFP only in the anterior blastomeres of the four-cell 
stage, whereas 67% express no detectable GFP (n = 15) at this stage 
(Figure 5, B and C). The substantial fraction of transgene-bearing, 
four-cell-stage embryos that lack detectable GFP fluorescence is 
likely due to the time required for maturation of the GFP chro-
mophore (Reid and Flynn, 1997), which is long relative to the dura-
tion of the four-cell stage. The anterior expression pattern matches 
that of endogenous GLP-1 protein, indicating that the glp-1 3′ UTR 
FIGURE 5: POS-1 and GLD-1 binding are independently required to 
repress a glp-1 3′ UTR reporter in embryos. (A) Schematic of reporter 
constructs used in this study. (B) Representative images of four-cell 
embryos with the listed reporter or experimental condition. (C) Table 
of results. No GFP, the percentage of embryos with no detectable 
GFP; anterior, the percentage of embryos expressing GFP in the two 
anterior blastomeres; posterior, the percentage of embryos 
expressing GFP in the two posterior blastomeres; n is the number of 
embryos observed.
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increased expression of GFP in the syncytial region of the germline 
(Figure 6B; glp-1 ∆GBM, n = 19).
SPN-4 does not directly activate glp-1 translation 
in the germline
The RRM-containing protein SPN-4 is a potential candidate for the 
activating factor that operates through the GDE in early embryos. 
SPN-4 is expressed throughout all cells of the embryo during the 
four-cell stage (Ogura et al., 2003), and GLP-1 expression is unde-
tectable in embryos lacking SPN-4 (Ogura et al., 2003). In addition, 
SPN-4 and POS-1 compete for binding to the nos-2 3′ UTR in vitro 
(Jadhav et al., 2008). To determine whether SPN-4 activates expres-
sion of the glp-1 3′ UTR reporter, we observed the pattern of GFP 
expression in four-cell embryos as a function of SPN-4 knockdown. 
Forty-eight percent of untreated four-cell embryos carrying the 
glp-1 WT reporter described earlier exhibit GFP expression in the 
anterior cells (n = 28; Figure 7A), whereas only 11% of spn-4(RNAi) 
four-cell embryos had detectable GFP in the anterior cells (n = 38). 
embryos (Figure 6B; glp-1 ∆5′ PRE, n = 18). In contrast, mutation of 
the 3′ PRE results in slightly reduced GFP expression in the mitotic 
region of the germline (Figure 6B; glp-1 ∆3′ PRE, n = 16) relative to 
the wild-type glp-1 reporter. Mutation of both the 5′ and 3′ PREs 
results in a further reduction in reporter expression throughout the 
distal arm of the gonad (Figure 6B; glp-1 ∆5′ 3′ PRE, n = 18). This 
apparent decrease is not dependent on POS-1, as pos-1(RNAi) has 
no apparent effect on expression of the wild-type reporter in the 
germline relative to worms fed with an empty feeding vector (Figure 
6B; glp-1 WT; mock, n = 12, vs. glp-1 WT; pos-1(RNAi), n = 8). Taken 
together, these results suggests that the 5′ and 3′ PRE mutations 
also disrupt a regulatory element that participates in translational 
activation of glp-1 mRNA in the distal arm of the germline and that 
POS-1 does not regulate glp-1 mRNA in the germline. Thus another 
RNA-binding protein may recognize this element and promote glp-
1 translation. This additional factor is unlikely to be GLD-1, as the 
GBM is involved in translational repression of glp-1 in the syncytial 
region. A reporter carrying a mutation in the GBM displays slightly 
FIGURE 6: Mutation of the 3′ PRE decreases glp-1 reporter expression independently of POS-1. (A) Representative 
confocal fluorescence images of the listed reporter strains or experimental condition. White asterisks mark the distal 
end of the gonad, and white arrows mark decreased reporter expression in the meiotic region of ∆5′ 3′ PRE and ∆3′ PRE 
reporter strains. (B) Quantification of confocal pixel intensities. Reporter expression for each strain was quantified using 
the image quantification software ImageJ as described in Materials and Methods. Each of the untreated transgenic 
strains was normalized to the average pixel intensity of the first 10% of the gonad of worms expressing the glp-1 WT 
reporter, and each of the RNAi experiments was normalized to the average pixel intensity of the first 10% of mock-
treated animals. Plotted data represent the mean intensity per bin ± one SEM. Traces represent the quantification of 
images taken of the strain listed in the legends at the upper right of each plot.
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which mediates the translational activation of multiple transcripts in 
the distal arm of the germline by extending their shortened poly(A) 
tails and thus permitting translation (Wang et al., 2002; Hansen 
et al., 2004; Eckmann et al., 2004; Suh et al., 2006). GLD-2 requires 
the association of a specificity factor to target it to mRNAs. Two such 
specificity factors have been identified: GLD-3 and RNP-8 (Wang 
et al., 2002; Eckmann et al., 2004; Kim et al., 2010). The GLD-2/
GLD-3 complex promotes meiotic entry and spermatogenesis 
(Wang et al., 2002; Eckmann et al., 2002, 2004), whereas the GLD-2/
RNP-8 complex promotes oogenesis (Kim et al., 2009, 2010). Given 
the catalytic activity and biological roles of these complexes, they 
may play a role in the translational activation of glp-1.
To test the requirement for each of these proteins in the regula-
tion of glp-1 translation, we reduced the level of their expression in 
worms carrying the glp-1 WT reporter by feeding worms bacteria 
expressing double-stranded RNA targeted against the gene of in-
terest. If the proteins are required for translational activation of glp-1 
mRNA, the level of reporter expression observed in the germline 
should decrease relative to worms treated with an empty feeding 
vector. We do not observe a decrease in reporter expression 
(Supplemental Figure S3), suggesting that translational activation of 
glp-1 mRNA in the germline is not dependent on GLD-2–mediated 
cytoplasmic polyadenylation.
Taken together, consistent with previous work, the results lead to 
the conclusion that translational control of glp-1 requires both re-
pressive and activating elements. GLD-1 binds to the GRE and is 
required for repression. POS-1 also binds to the GRE in vitro, but 
binding to the GRE has no effect on glp-1 expression in worms. 
POS-1(1-206) also binds with equivalent affinity to the GDE in vitro, 
but binding is required for repression, not activation. We suggest 
that POS-1 represses translation by competing with an unidentified 
factor that binds to the GDE to promote translation. This would 
explain why two POS-1–binding sites with equivalent affinities, sep-
arated by only five nucleotides, contribute disparately to glp-1 regu-
lation, and why the PRE is necessary but not sufficient to confer 
regulation in worms.
DISCUSSION
In this report, we describe the translational regulation of the 
C. elegans Notch homologue glp-1 by the CCCH-type tandem zinc 
finger protein POS-1 and the STAR-domain protein GLD-1. The 
glp-1 3′ UTR contains a cluster of regulatory elements comprising 
two PREs, each of which overlaps with a GBM. POS-1 and GLD-1 
each bind to their respective sites in vitro, but POS-1 recognizes its 
sites with a higher affinity than GLD-1. In the presence of POS-1, 
GLD-1 binding to its site is inhibited. However, both the 3′ PRE and 
the GBM are required for translational repression of glp-1 3′ UTR 
reporter in the four-cell embryo, suggesting that both POS-1 and 
GLD-1 translationally repress glp-1 mRNA through this cluster of 
binding sites. In addition, the 3′ PRE but not the 5′ PRE is required 
for regulation of glp-1. Mutation of both PREs or the 3′ PRE alone 
results in decreased reporter expression in the distal germline, 
where POS-1 is not expressed. This suggests that another factor is 
required for translational activation of glp-1 mRNA, and it recog-
nizes the PREs. Here, we present evidence for a cluster of functional 
overlapping binding sites within the glp-1 3′ UTR.
Translational repression by POS-1 and GLD-1
Our data suggest that POS-1 and GLD-1 directly and independently 
repress glp-1 translation in the early embryo. Although binding sites 
for both proteins within the glp-1 3′ UTR are required for transla-
tional repression of a glp-1 3′ UTR reporter in vivo, the in vitro 
This suggests that SPN-4 is indeed required to activate expression 
from the glp-1 3′ UTR reporter in the early embryo. However, this 
activation is not mediated through the GDE, as SPN-4 knockdown 
has no effect on GFP expression in four-cell embryos carrying a re-
porter bearing the ∆3′ PRE mutation (∆3′ PRE: 100% of embryos 
have anterior and posterior GFP expression, n = 30; ∆3′ PRE spn-
4(RNAi): 93% of embryos have anterior GFP expression and 97% 
have posterior GFP expression, n = 30; Figure 7A). Furthermore, 
purified SPN-4–RBD does not bind to either the glp-1 fragment 
(Figure 7B) or a longer RNA containing the entire glp-1 GDE (un-
published data) in vitro. Thus SPN-4 is not likely to compete with 
POS-1 for binding to the GDE. Consistent with this interpretation, 
SPN-4 was previously observed to interact with a distant element of 
the glp-1 3′-UTR by yeast three-hybrid assay (Ogura et al., 2003).
The cytoplasmic poly(A) polymerase GLD-2 and its 
specificity factors GLD-3 and RNP-8 are not required 
for translational activation of glp-1 mRNA
To identify proteins that are responsible for the translational activa-
tion of glp-1 mRNA in the germline, we took a candidate approach 
and screened the expression pattern of the glp-1 WT reporter in the 
context of RNA interference (RNAi) knockdown by feeding. One po-
tential candidate is the cytoplasmic poly(A) polymerase GLD-2, 
FIGURE 7: SPN-4 activates glp-1 translation indirectly. 
(A) Representative images of four-cell embryos carrying the listed 
reporter construct (left) and treated as described (top). Bottom, table 
of results. Anterior and posterior, the percentage of four-cell embryos 
with detectable GFP fluorescence in either the anterior or posterior 
cells, respective. None, the percentage of embryos with no 
detectable GFP fluorescence. (B) Representative gel shift data for 
SPN-4(50-135). The protein concentration used in each lane is labeled 
above the gel.
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is not expressed, as this mutation likely targets a regulatory element 
that is recognized by another protein in the germline.
The overlap between regulatory elements suggests a competi-
tion model for POS-1–mediated translational regulation of mRNAs. 
In this speculative model, POS-1 regulates its targets not by binding 
to mRNA and recruiting regulatory machinery, but instead by inter-
fering with the binding of other RNA-binding proteins that do re-
cruit regulatory machinery. Thus the regulatory role of a PRE in vivo 
is likely heavily dependent on its sequence context, as functional 
PREs should overlap with or be near regulatory elements recognized 
by other proteins. As a result, many PREs are likely to be bound by 
POS-1, but binding of POS-1 may not result in a change in the rate 
of translation or the stability of the associated mRNA. In support of 
this model is the observation that the addition of multiple PREs is 
not sufficient to confer patterned expression on an otherwise unpat-
terned 3′ UTR (Farley et al., 2008). More than 40% of C. elegans 
transcripts are predicted to contain at least one PRE (Farley et al., 
2008), and so finding the functional binding sites likely presents 
multiple challenges in bioinformatics and systems biology. Thus 
identifying functional PREs in vivo will likely require the integration 
of multiple data sets describing the binding sites for other RNA-
binding proteins in vivo. By investigating the specificity of additional 
factors, we may identify additional binding sites that overlap with 
PREs and may be occupied by POS-1 in vivo.
MATERIALS AND METHODS
Cloning and purification of POS-1, GLD-1, and SPN-4
DNA encoding amino acids 1–206 of POS-1 cloned into the protein 
expression vector pMAL-c2x (New England BioLabs, Ipswich, MA) 
was graciously provided by Tom Evans (University of Colorado 
Anshutz Medical Campus, Aurora, CO). The plasmid was trans-
formed into Escherichia coli strain BL21 (DE3). Protein expression 
was induced with 1 mM isopropyl-β-d-thiogalactoside (IPTG) and 
100 μM Zn(OAc)2. The cells were lysed using a microfluidizer, and 
the lysate was purified using an amylose column (New England 
BioLabs), followed by a Source Q column (GE Healthcare Life 
Sciences, Piscataway, NJ) and a HiPrep 16/60 Sephacryl S-200 
column (GE Healthcare Life Sciences). After the final column, the 
protein was dialyzed into 25 mM Tris, pH 8.0, 25 mM NaCl, 2 mM 
dithiothreitol (DTT), and 100 μM Zn(OAc)2, concentrated to ∼30 μM, 
and used for experiments.
DNA encoding amino acids 50–135 of SPN-4 was cloned into the 
protein expression vector pHMTc (Ryder et al., 2004), transformed 
into E. coli strain BL21 (DE3), and induced as described for POS-1 
1–206 but omitting the zinc acetate. Cells were lysed using a micro-
fluidizer, and the lysate was purified using an amylose column (New 
England BioLabs), followed by a HiTrap SP HP column (GE Health-
care Life Sciences) and a SourceQ column. Following the last col-
umn, the protein was dialyzed into 25 mM Tris, pH 8.0, 25 mM NaCl, 
and 2 mM DTT, concentrated to ∼20 μM, and used for experiments.
POS-1–RBD was expressed and purified from pHMTc-
POS-1(80-180) as described previously (Farley et al., 2008). GLD-1 
was expressed and purified from pHMTc-GLD1(135-336) as de-
scribed (Ryder et al., 2004).
Fluorescence labeling of RNAs
RNA oligonucleotides were synthesized by Integrated DNA 
Technologies (Coralville, IA) and fluorescently labeled on their 3′ 
ends via periodate oxidation, followed by reaction with fluorescein-
5-thiosemicarbazide (Sigma-Aldrich, St. Louis, MO). Unreacted label 
was purified away via G-25 spin column. A detailed protocol is avail-
able (Pagano et al., 2011).
competition results support the hypothesis that binding of POS-1 
and GLD-1 is mutually exclusive. GLD-1 forms homodimers in the 
absence of RNA, and these dimers bind to RNA directly (Ryder 
et al., 2004). Moreover, GLD-1 contacts sequence outside its seven-
nucleotide motif (Ryder et al., 2004; Wright et al., 2011), suggesting 
that tight binding of proteins to immediately flanking sequences 
would antagonize GLD-1 binding. Thus, although POS-1 and GLD-1 
cooperate to ensure that glp-1 translation remains repressed, our 
data show no evidence for positive cooperativity in their ability to 
recognize the glp-1 3′-UTR.
The apparent independence of POS-1 and GLD-1 regulation of 
glp-1 may be a consequence of the differing spatial, temporal, and 
subcellular localization patterns of each protein. Because POS-1 is 
expressed earlier than GLD-1 (Tabara et al., 1999; Jones et al., 1996), 
glp-1 is likely regulated only by POS-1 during the one- and two-cell 
stages. Once GLD-1 translation begins, it may become the primary 
negative regulator of glp-1. Because POS-1 antagonizes binding of 
GLD-1 to the glp-1 3′ UTR, the handoff to GLD-1 mediated repres-
sion would likely require inactivation or turnover of POS-1.
Alternatively, the differences in subcellular localization between 
POS-1 and GLD-1 may be indicative of different locations of glp-1 
repression in the early embryo. In the germline, GLD-1 is present in 
cytoplasmic granules that also contain the DDX6-like RNA helicase 
CGH-1 (Noble et al., 2008). Both GLD-1 and CGH-1 have been im-
plicated in the translational repression and stabilization of a number 
of maternal mRNAs in the germline that are destined for translation 
after fertilization (Scheckel et al., 2012). This suggests that these 
granular structures play a role in the storage of maternal mRNAs. 
Indeed, the glp-1 3′ UTR is sufficient for localization of a reporter 
mRNA to these granules in the meiotic region of the germline 
(Noble et al., 2008), and removal of the GLD-1–binding site results 
in decreased subcellular localization of reporter mRNA in the ger-
mline (Noble et al., 2008). GLD-1 also localizes to granular structures 
in the cytoplasm of early embryos (Jones et al., 1996), but the role 
of embryonic cytoplasmic granules is unknown. It is possible that 
glp-1 mRNA localizes to GLD-1–containing granules in the embryo 
in a GLD-1–dependent manner. If this is the case, two distinct pools 
of glp-1 mRNA could exist within the posterior of the four-cell em-
bryo: a cytoplasmic pool that requires POS-1 for translational re-
pression and a granular pool that requires GLD-1 for translational 
repression. Thus each protein would play a role in the translational 
regulation of glp-1 without forming a ternary complex.
POS-1–mediated translational repression
Our data demonstrate that the 5′ and 3′ PREs within the glp-1 3′ 
UTR are not functionally equivalent. In four-cell embryos, mutation 
of the 3′ PRE results in aberrant translation of a reporter in the ante-
rior blastomeres, whereas mutation of the 5′ PRE has no effect on 
the expression of a reporter. In the germline, mutation of the 3′ PRE 
results in decreased reporter expression relative to a reporter bear-
ing the wild-type glp-1 3′ UTR, whereas mutation of the 5′ PRE has 
no apparent effect. The discrepancy between the function of these 
binding sites is likely explained by the overlap of the 3′ PRE (but not 
the 5′ PRE) with a previously identified activating regulatory element 
called the glp-1 derepression element (Marin and Evans, 2003). 
Mutations within this element cause either no or reduced expression 
of a reporter without having a detectable difference on the expres-
sion level of the reporter mRNA (Marin and Evans, 2003). Thus the 
GDE is required for translational activation, and mutations that tar-
get the 3′ PRE are likely to perturb the function of this element as 
well. This also explains why mutations of the 3′ PRE result in de-
creased reporter expression in a region of the gonad where POS-1 
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images were collected using a 40× Plan Neofluar oil immersion ob-
jective on a Zeiss Axioskop 2 plus microscope (Carl Zeiss, Jena, 
Germany).
Confocal microscopy was performed on a Leica DMIRE2 micro-
scope outfitted with a Leica TCS SP2 scanner (Leica, Wetzlar, 
Germany) using a 40× oil immersion/1.25 numerical aperture objec-
tive. A single confocal section through the syncytial region of the 
distal gonad arm was imaged for each worm. Samples were excited 
with a 488-nm laser at 100% intensity, and the photomultiplier tube 
collected emitted light between 500 and 600 nm with a gain of 
610 HV. Each scan line is the average of eight reads.
Confocal images were quantified using the segmented line tool 
in ImageJ (National Institutes of Health, Bethesda, MD; Schneider 
et al., 2012), using a method adapted from Wright et al. (2011). A 
7-pixel-wide line was drawn through a row of nuclei beginning at the 
distal end of the gonad and ending at the bend in the distal arm, 
and the average pixel intensity across this line was segmented into 
30 equally sized bins. Segmentation and averaging were performed 
using Perl scripts that are available upon request. The measured 
average pixel intensity was determined for multiple worms, and 
values were averaged together to give a composite pixel intensity 
for each strain.
RNAi knockdown
Embryos were harvested from adult worms by treatment with 0.5 N 
NaOH and 2% Clorox bleach, washed twice with water, and then 
transferred to NGM plates supplemented with 1 mM IPTG and 
100 μg/ml ampicillin and seeded with HT115(DE3) bacteria trans-
formed with a construct expressing double-strand RNA targeting 
the gene of interest. Before seeding, bacteria transformed with 
spn-4–expressing, gld-2–expressing (Kim et al., 2010), gld-3–
expressing (Eckmann et al., 2004), or rnp-8–expressing (Kim et al., 
2010) constructs were induced at ∼0.4 OD600 with 1 mM IPTG. Con-
structs targeting pos-1, gld-2, gld-3, and rnp-8 were obtained from 
the Ahringer feeding library (Kamath et al., 2003). The construct 
targeting spn-4 was generated by cloning the PCR product ampli-
fied from spn-4 cDNA with the following primers into the NcoI site 
of the C. elegans feeding vector L4440: forward, 5′-GAGCCATG-
GTGCAAAACACACAGATATTTACTAAC-3′; reverse, 5′-GAGCCAT-
GGACTGGCTTGACGATTCTTTTGG-3′; Kamath and Ahringer, 
2003). Worms were maintained at 25ºC for 2 d, and the P0 genera-
tion was imaged as described earlier. Greater than 95% embryonic 
lethality was observed in the F1 generation of pos-1– or spn-4–
treated worms.
Fluorescence electrophoretic mobility shift assays
Fluorescence electrophoretic mobility shift assays were essentially 
performed and analyzed as described in Pagano et al. (2011). 
Briefly, 2 nM fluorescently labeled RNA in equilibration buffer 
(50 mM Tris, pH 8.0, 100 mM NaCl, 5 μM Zn(OAc)2, 0.01% IGEPAL 
CA-630, and 0.01 mg/ml tRNA) was mixed with various concentra-
tions of either POS-1 or GLD-1 and equilibrated at room tempera-
ture for 3 h. The protein-bound and free RNA was then resolved on 
a 1× Tris-borate buffer (TB) native 5% polyacrylamide slab gel run at 
120 V for approximately 1 h at 4 ºC.
Competition assays were performed in essentially the same man-
ner, except that a fixed concentration of POS-1 or GLD-1 was added 
to the labeled RNA in equilibration buffer to achieve ∼70% bound 
RNA in the absence of competitor protein. Then various amounts 
of competitor protein were added to each reaction and incubated 
for at least 3 h. The reactions were then loaded onto a 1× TB native 
5% polyacrylamide slab gel run at 120 V for 3 h at 4ºC to resolve 
POS-1– and GLD-1–bound complexes. Gels were quantified using 
Image Gauge (Fujifilm, Tokyo, Japan), and the fraction of protein-
bound RNA was determined by quantifying the ratio of the back-
ground-corrected pixel intensity of the protein-bound RNA relative 
to the sum of the background-corrected pixel intensities of each 
RNA species. Two independent replicates of each competition ex-
periment involving POS-1 were performed, and five independent 
replicates were performed with POS-1–RBD.
Cloning of reporter constructs
The glp-1 3′ UTR was amplified via PCR using Elongase (Invitrogen, 
Carlsbad, CA) from worm genomic DNA using primers that added 
the attB2R and attB3 sites to the 5′ and 3′ ends of the product, re-
spectively. The PCR product was then cloned into pDONRP2RP3 
using BP Clonase II (Invitrogen). Site-specific mutations in the glp-1 
3′ UTR were introduced via QuikChange mutagenesis using Pfu 
Turbo. Each of the resulting variants of the glp-1 3′ UTR was 
then used in a multisite gateway reaction with plasmids bearing the 
mex-5 promoter (pCM1.111) and MODC PEST::GFP::H2B ORF 
(pBMF2.7) to generate constructs for integration. The gateway reac-
tion was catalyzed with LR Clonase II Plus (Invitrogen), and the 
promoter::ORF::3′ UTR fusions were cloned into the MosSCI inte-
gration vector pCFJ150.
Generation and verification of transgenic strains
Single-copy integrated transgenic worms strains were generated by 
MosSCI (Frøkjaer-Jensen et al., 2008). Plasmids bearing the trans-
gene to be integrated were microinjected into the gonads of young 
adult worms of strain EG4322 along with pharyngeal- and body wall–
expressed mCherry markers and a constitutive germline-expressed 
Mos1 transposase. Prior to injection, worms were maintained at 15ºC 
on NGM agar plates seeded with Comamonas (DA1877). Worms 
were propagated for two generations and screened for successful 
integration by checking for wild-type movement without expression 
of the mCherry extrachromosomal array markers. Putative integrants 
were confirmed by PCR using a transgene-specific primer and a worm 
genome–specific primer. These PCR products were then sequenced 
to validate the mutations in the reporter’s 3′ UTR.
Imaging and quantification of fluorescent reporter strains
Before imaging, worms were maintained at 25ºC for at least 24 h to 
promote GFP folding. Embryos were obtained by dissecting adult 
worms and then mounted on 2% agarose pads, and whole worms 
were paralyzed with 0.4 mM levamisole and mounted on 2% 
agarose pads. Both differential interference contrast and GFP 
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